ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660027 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660027; 2) Community: the network communities that were significantly associated with the response to NSC 660027; 3) Molecule: the relationships between components within communities and NSC 660027; 4) MDR: the compounds that were significantly associated with the NSC 660027.

NSC Compound Enrichment Correlation
NSC 744469 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate 0.0430505868034764 0.31435008
NSC 750685 Null 0.0430505868034764 0.10870578
NSC 753376 3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1-methyl-1H-indole 0.0430505868034764 -0.23139031
NSC 78714 Clothixamide maleate (USAN) 0.0430505868034764 0.030708667
NSC 140701 Sulfanilanilide, 4'-(9-acridinylamino)-, monohydrochloride 0.0435808621943462 0.56825964
NSC 241494 Null 0.0435808621943462 0.22014212
NSC 249992 M-AMSA 0.0435808621943462 0.7431664
NSC 295500 Camptothecin Derivative 0.0435808621943462 0.62229908
NSC 306911 .beta.-D-Glucopyranose, 2,3-O-(diethylstannylene)- 0.0435808621943462 0.012533306
NSC 5159 X 465A 0.0435808621943462 0.30779405
Total:52  Current:49    [First] [Prev] [Next] [Last]